RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 65 filers reported holding RA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $34,000 | -98.8% | 700 | -98.8% | 0.00% | -100.0% |
| Q4 2019 | $2,814,000 | +16452.9% | 59,962 | +8466.0% | 0.00% | – |
| Q3 2019 | $17,000 | -19.0% | 700 | -0.7% | 0.00% | – |
| Q2 2019 | $21,000 | +31.2% | 705 | +0.7% | 0.00% | – |
| Q1 2019 | $16,000 | +23.1% | 700 | -0.4% | 0.00% | – |
| Q4 2018 | $13,000 | -18.8% | 703 | -18.4% | 0.00% | – |
| Q3 2018 | $16,000 | – | 862 | +5287.5% | 0.00% | – |
| Q2 2018 | $0 | – | 16 | +128.6% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 7 | -99.3% | 0.00% | – |
| Q3 2017 | $16,000 | +220.0% | 1,069 | +381.5% | 0.00% | – |
| Q1 2017 | $5,000 | -37.5% | 222 | -55.2% | 0.00% | – |
| Q4 2016 | $8,000 | – | 495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,851,808 | $20,453,000 | 1.57% |
| NEA Management Company, LLC | 5,493,636 | $29,171,000 | 1.30% |
| Foresite Capital Management IV, LLC | 450,000 | $2,390,000 | 0.99% |
| Novo Holdings A/S | 1,465,838 | $7,784,000 | 0.98% |
| Consonance Capital Management LP | 1,454,761 | $7,725,000 | 0.71% |
| VHCP Management II, LLC | 544,612 | $2,892,000 | 0.70% |
| ACUTA CAPITAL PARTNERS, LLC | 270,000 | $1,434,000 | 0.23% |
| Athanor Capital, LP | 67,150 | $357,000 | 0.16% |
| Rock Springs Capital Management LP | 600,000 | $3,186,000 | 0.14% |
| Eventide Asset Management | 388,000 | $2,060,000 | 0.10% |